T-cell prolymphocytic leukaemia and Lymph follicular hypertrophy - from FDA reports

Summary

Lymph follicular hypertrophy is found among people with T-cell prolymphocytic leukaemia, especially for people who are female, 60+ old, take medication Pentostatin and have Non-hodgkin's lymphoma. This review analyzes which people have Lymph follicular hypertrophy with T-cell prolymphocytic leukaemia. It is created by eHealthMe based on reports of 10 people who have T-cell prolymphocytic leukaemia from FDA , and is updated regularly.

What to expect?

If you have T-cell prolymphocytic leukaemia and Lymph follicular hypertrophy, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who have T-cell prolymphocytic leukaemia and Lymph follicular hypertrophy

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Oct, 19, 2017

10 people who have T-Cell Prolymphocytic Leukaemia and Lymph Follicular Hypertrophy are studied.


Number of reports submitted per year:

Would you have Lymph follicular hypertrophy when you have T-cell prolymphocytic leukaemia?

Gender of people who have T-Cell Prolymphocytic Leukaemia and experience Lymph Follicular Hypertrophy *:

  • female: 70 %
  • male: 30 %

Age of people who have T-Cell Prolymphocytic Leukaemia and experience Lymph Follicular Hypertrophy *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 10 %
  • 60+: 90 %

Top co-existing conditions for these people *:

  • Preventive Health Care (1 person, 10.00%)
  • Non-Hodgkin's Lymphoma (1 person, 10.00%)

Most common drugs for these people *:

  • Pentostatin (6 people, 60.00%)
  • Campath (3 people, 30.00%)
  • Cyclophosphamide (1 person, 10.00%)
  • Bactrim (1 person, 10.00%)

Top symptoms for these people *:

  • Non-Hodgkin's Lymphoma (6 people, 60.00%)
  • Abdominal Pain (6 people, 60.00%)
  • Herpes Zoster (5 people, 50.00%)
  • Gastrointestinal Haemorrhage (5 people, 50.00%)
  • Confusional State (5 people, 50.00%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Lymph follicular hypertrophy and T-cell prolymphocytic leukaemia?

Expand the study to include reports from both FDA and eHealthMe

Lymph follicular hypertrophy and T-cell prolymphocytic leukaemia from FDA and eHealthMe reports

T-Cell Prolymphocytic Leukaemia

T-cell prolymphocytic leukaemia (a aggressive type of t cell cancer) (latest reports from 173 T-cell prolymphocytic leukaemia patients)

Lymph Follicular Hypertrophy

Lymph follicular hypertrophy (an increase in the size of the lymph node follicles) has been reported by people with rheumatoid arthritis, multiple sclerosis, high blood pressure, psoriasis, osteoporosis (latest reports from 25,482 Lymph follicular hypertrophy patients).

Browse all symptoms of T-cell prolymphocytic leukaemia

a b c d e f g h i j k l m n o p q r s t u v w x y z

Could your drugs cause Lymph follicular hypertrophy

Lymph follicular hypertrophy

Other conditions that could case Lymph follicular hypertrophy

Lymph follicular hypertrophy

Related studies

What would happen?

Forecast new side effects and undetected conditions when you have T-cell prolymphocytic leukaemia and Lymph follicular hypertrophy.

Can you answer these questions?

More questions >

You may be interested in these reviews

More reviews >